CS Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2009	FY 2008	FY 2007
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Revenue	0.1	0.11	0.13	-	-	0
Revenue Growth (YoY)	-21.67%	-12.00%	-	-	-	-12.46%
Cost of Revenue	-	-	-	-	-	0
Gross Profit	0.1	0.11	0.13	-	-	0
Selling, General & Admin	0.08	0.11	0.15	0.23	0.36	1.12
Operating Expenses	0.08	0.11	0.15	0.23	0.36	1.12
Operating Income	0.02	0	-0.02	-0.23	-0.36	-1.12
Other Non Operating Income (Expenses)	-	-	-	-0.04	-0.05	-0.04
Pretax Income	0.02	0	-0.02	-0.27	-0.4	-1.17
Income Tax Expense	-	-	-	-	-	0
Net Income	0.02	0	-0.02	-0.27	-0.4	-1.17
Net Income to Common	0.02	0	-0.02	-0.27	-0.4	-1.17
Shares Outstanding (Basic)	148	137	111	0	0	-
Shares Outstanding (Diluted)	148	137	111	0	0	-
Shares Change (YoY)	33.49%	23.92%	114621.71%	-	-	-
EPS (Basic)	0.00	0.00	-0.00	-2.79	-4.16	-
EPS (Diluted)	0.00	0.00	-0.00	-2.79	-4.16	-
Free Cash Flow	-0.02	0.01	0.01	-0	-0.74	-0.02
Free Cash Flow Per Share	-	-	-	-0.00	-7.69	-
Gross Margin	100.00%	100.00%	100.00%	-	-	86.68%
Operating Margin	19.64%	0.69%	-17.45%	-	-	-146466.84%
Profit Margin	19.64%	0.69%	-17.45%	-	-	-152217.76%
Free Cash Flow Margin	-21.65%	9.95%	7.37%	-	-	-2021.80%
EBITDA	-	-	-	-0.23	-0.35	-1.12
D&A For EBITDA	-	-	-	0	0	0.01
EBIT	0.02	0	-0.02	-0.23	-0.36	-1.12
EBIT Margin	19.64%	0.69%	-17.45%	-	-	-
Revenue as Reported	0.1	0.11	0.13	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.